Interstitial Lung Diseases (ILD)

Pathologists are key members of the multidisciplinary and interprofessional team involved in the diagnosis, testing, and management of patients with interstitial lung diseases (ILDs) such as idiopathic pulmonary fibrosis (IPF), other chronic fibrosing ILDs (CF-ILDs) with a progressive phenotype, systemic sclerosis ILD (SSc-ILD), and childhood ILDs (chILDs). ASCP is committed to helping you be equipped with the knowledge, skills, and competencies needed for the diagnosis, testing, and care of patients with interstitial lung diseases.

Case-based Microlearning: Diagnostic Challenges in Respiratory-Fibrosing Interstitial Lung Diseases

This CME/CMLE-accredited, case-based microlearning activity is designed to help laboratory team members increase their knowledge, skills, and competence in diagnosing various interstitial lung diseases (ILDs) and making testing recommendations based on clinical practice guidelines, while also increasing their understanding of the signs, symptoms, and disease burden of ILDs. Every few days, several questions will be emailed or sent through the Qstream app, allowing learners to hone their diagnostic and decision-making skills in minutes each week.

This case-based microlearning activity includes the following topics: best practices in the interpretation of lung biopsy results in patients with ILDs; histologic findings that may indicate an alternate diagnosis; clinical practice guidelines for ILDs; the critical importance of multidisciplinary discussions in the diagnosis and management of patients with ILDs; ILD epidemiology, risk factors, comorbidities, and disease burden; and current antifibrotic treatment options for ILDs.

Activity Agenda

  • 21 case-based microlearning questions followed by detailed explanations
  • Questions are delivered 3 at a time via email

Learning Objectives

Upon completion of this activity, you should be able to:

  • Utilize patient data (e.g., lung biopsy slides, clinical information) to differentiate between ILDs and potential mimics in lung biopsies in cases involving patients with ILDs
  • Recommend appropriate biopsy and serologic testing in cases involving patients with ILDs in accordance with clinical practice guidelines
  • Differentiate between different subtypes of ILDs based on knowledge of the signs and symptoms, disease course, and disease burden of ILDs

Faculty

Sanjay Mukhopadhyay, MD, FASCP, Director of Pulmonary Pathology, Cleveland Clinic; Associate Editor (Pulmonary) for the American Journal of Clinical Pathology and Associate Editor (social media) for Modern Pathology

Jefree J. Schulte, MD, FASCP, Assistant Professor, Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health

Sara O. Vargas, MD, Staff Pathologist, Director of Pulmonary Pathology, and Director of Quality and Patient Safety, Department of Pathology, Boston Children’s Hospital; Staff Pathologist, Brigham and Women’s Hospital; Associate Professor, Harvard Medical School

Credits

This microlearning series offers 1.0 CME/CMLE credits.

Register Now

This course allows you to claim credit once you have completed the microlearning education in QStream and received your completion notice via email. Do not attempt to claim credit until you have completed the microlearning education in QStream.

  • Sign up for a Qstream account.
  • Enroll in the Diagnostic Challenges in Respiratory-Fibrosing Interstitial Lung Disease Qstream.

Register Now

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

CME Information

The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

The ASCP designates this online microlearning activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.